Kyowa Kirin gets EC approval for CRYSVITA (burosumab) to treat X-Linked hypophosphataemia in older…
It was previously approved for the treatment of XLH with radiographic evidence of bone disease in children one year of age and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Crysvita
US FDA grants approval to Ultragenyx Pharmaceutical for Crysvita
The drug has been approved to treat patients with tumor-induced osteomalacia (TIO), a rare disease that is characterized by the…